Advisory Services Network’s Alaunos Therapeutics TCRT Stock Holding History

Advisory Services Network’s Portfolio TCRT Stock Details TCRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	–	–	3037
2021 Q2	$0	Buy	+1	New	+$467	﹤0.01%	3644
2021 Q1	–	Sell	-1	Closed	–	–	2775
2020 Q4	$0	Hold	1	–	–	﹤0.01%	3689
2020 Q3	$0	Buy	+1	New	+$442	﹤0.01%	3644
2020 Q2	–	Sell	-1	Closed	–	–	2560
2020 Q1	$0	Hold	1	–	–	﹤0.01%	3277
2019 Q4	$1K	Hold	1	–	–	﹤0.01%	3012
2019 Q3	$1K	Hold	1	–	–	﹤0.01%	2750
2019 Q2	$1K	Hold	1	–	–	﹤0.01%	2748
2019 Q1	$1K	Hold	1	–	–	﹤0.01%	2466
2018 Q4	$0	Hold	1	–	–	﹤0.01%	2660
2018 Q3	$1K	Hold	1	–	–	﹤0.01%	2438
2018 Q2	$0	Hold	1	–	–	﹤0.01%	2685
2018 Q1	$1K	Hold	1	–	–	﹤0.01%	2517
2017 Q4	$1K	Sell	1 -7	-88%	-$5.03K	﹤0.01%	2484
2017 Q3	$7K	Buy	8 +7	+700%	+$6.22K	﹤0.01%	1756
2017 Q2	$1K	Hold	1	–	–	﹤0.01%	2243
2017 Q1	$1K	Buy	+1	New	+$931	﹤0.01%	2128
2016 Q3	$1K	Buy	+1	New	+$804	﹤0.01%	1926
2016 Q2	–	Hold	0	–	–	–	1943
2016 Q1	–	Hold	0	–	–	–	1776

Other funds holding TCRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisory Services Network's TCRT Position: Q3 2021 in Review

Advisory Services Network sold out of Alaunos Therapeutics (TCRT) in Q3 2021, closing a stake of 1 share.

Advisory Services Network first reported a position in TCRT in Q3 2016 and held it in 17 quarters. The position peaked at $7K in Q3 2017. 162 funds tracked by Wall St. Rank hold TCRT as of Q3 2021.

Advisory Services Network reported no remaining Alaunos Therapeutics position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 1 Alaunos Therapeutics share in Q3 2021.
Advisory Services Network first reported a position in Alaunos Therapeutics in Q3 2016 and held it in 17 quarters.
Advisory Services Network's Alaunos Therapeutics position peaked at $7K in Q3 2017.
162 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.